GlassScriptPhysician profile
Michael J Grushko
NPI 1922274364
$11,948.82
in general payments reported to CMS, 2019-2025
20 companies · $3,663 in 2025
The $3,663 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,862 · 2020: $537 · 2021: $768 · 2022: $492 · 2023: $462 · 2024: $3,165 · 2025: $3,663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,698 · Food and Beverage: $3,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,697.67 |
| Food and Beverage | $3,592.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,952.40 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Solia |
| Medtronic, INC. | $1,907.66 | 2021-2025 | Symplicity G3, Linq II, Selectsecure |
| Medtronic Vascular, INC. | $1,651.66 | 2019 | |
| Boston Scientific Corporation | $1,242.49 | 2020-2024 | Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $836.26 | 2019-2025 | Carto 3 |
| Abiomed | $483.51 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $395.95 | 2019-2024 | Lifevest |
| Angiodynamics, INC. | $320.70 | 2024-2025 | Alphavac |
| Abbott Laboratories | $221.16 | 2020-2025 | Aveir, Perclose Prostyle |
| Janssen Pharmaceuticals, INC | $212.76 | 2019 | |
| Impulse Dynamics (USA) INC. | $155.15 | 2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $118.41 | 2020 | |
| Novo Nordisk INC | $107.36 | 2022 | |
| Scpharmaceuticals INC. | $93.66 | 2024-2025 | |
| Philips North America LLC | $59.60 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $45.55 | 2025 | Assure Wcd |
| Novartis Pharmaceuticals Corporation | $38.30 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $36.13 | 2023 | Verquvo |
| Cardiovascular Systems INC. | $35.36 | 2021-2022 | |
| Amgen INC. | $34.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Grushko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.